Test Name: HLA-B27
Health Link Test Code: XHLA
LIS Test Code: B27
CPT Code(s): 81374
Methodology: Reverse SSO detected by Luminex xMAP (Multi-Analyte Profiling)
The HLA-B27 antigen is associated with Ankylosing Spondylitis and several other related diseases. The absence of B27 may be used to rule out the associated disease.
Days Performed: Mon-Fri.
In-Lab Turnaround Time: 5 days.
Stat In-Lab Turnaround Time: Not available stat.
Collection Container: Lavender top
Also Acceptable: Yellow top(with ACD-A/B anticoagulant)
Do NOT open tube.
Collection Volume: Full 4 mL tube
Pediatric Collection Volume: 2 mL
Testing Volume: 4 mL
Pediatric Testing Volume: 2 mL
Transport specimen to UWHC Hospital Laboratory.
|Negative:||HLA-B27 antigen not detected|
|Positive:||HLA-B27 antigen detected|
This test was developed and its performance characteristics determined by this laboratory. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.